We are live on ! Find out more
MCM

Maple Capital Management Portfolio holdings

AUM $1.49B
1-Year Est. Return 23.46%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+23.46%
3 Year Est. Return
+94.39%
5 Year Est. Return
+123.75%
10 Year Est. Return
+415.38%
AUM
$877M
AUM Growth
-$41.2M
Cap. Flow
-$13.2M
Cap. Flow %
-1.51%
Top 10 Hldgs %
50.86%
Holding
99
New
4
Increased
55
Reduced
31
Closed
2

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$12.2M
2
VZ icon
Verizon
VZ
+$5.61M
3
CMG icon
Chipotle Mexican Grill
CMG
+$3.52M
4
PNC icon
PNC Financial Services
PNC
+$2.5M
5
LLY icon
Eli Lilly
LLY
+$1.87M

Sector Composition

Rank Sector Weight
1 Technology 31.32%
2 Healthcare 15.24%
3 Financials 14.2%
4 Consumer Discretionary 11.19%
5 Communication Services 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWX icon
76
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
$346K 0.04%
7,363
+1,907
+35% +$93.3K
MDT icon
77
Medtronic
MDT
$108B
$343K 0.04%
4,380
+972
+29% +$81.4K
CF icon
78
CF Industries
CF
$18.4B
$333K 0.04%
3,886
-60
-2% -$4.74K
IJS icon
79
iShares S&P Small-Cap 600 Value ETF
IJS
$8.14B
$325K 0.04%
3,646
VMC icon
80
Vulcan Materials
VMC
$36.9B
$318K 0.04%
1,574
-47
-3% -$10.2K
TRMK icon
81
Trustmark
TRMK
$2.71B
$314K 0.04%
14,428
BSV icon
82
Vanguard Short-Term Bond ETF
BSV
$44.6B
$312K 0.04%
4,156
+90
+2% +$6.79K
IWB icon
83
iShares Russell 1000 ETF
IWB
$47.7B
$284K 0.03%
1,208
T icon
84
AT&T
T
$167B
$272K 0.03%
18,128
-720
-4% -$10.6K
IDXX icon
85
Idexx Laboratories
IDXX
$43.9B
$265K 0.03%
605
CTAS icon
86
Cintas
CTAS
$84.4B
$261K 0.03%
2,172
+64
+3% +$7.97K
ROK icon
87
Rockwell Automation
ROK
$51.9B
$237K 0.03%
829
VEA icon
88
Vanguard FTSE Developed Markets ETF
VEA
$227B
$233K 0.03%
5,335
+893
+20% +$40.9K
BBY icon
89
Best Buy
BBY
$18.6B
$233K 0.03%
3,354
+660
+24% +$51K
JEF icon
90
Jefferies Financial Group
JEF
$13B
$231K 0.03%
+6,316
New +$226K
GE icon
91
GE Aerospace
GE
$375B
$228K 0.03%
2,581
+20
+0.8% +$1.8K
BDX icon
92
Becton Dickinson
BDX
$43.8B
$217K 0.02%
841
+9
+1% +$2.43K
EW icon
93
Edwards Lifesciences
EW
$47.8B
$217K 0.02%
3,136
+11
+0.4% +$884
ABBV icon
94
AbbVie
ABBV
$454B
$203K 0.02%
+1,362
New +$200K
VTI icon
95
Vanguard Total Stock Market ETF
VTI
$655B
$201K 0.02%
+948
New +$210K
F icon
96
Ford
F
$58.5B
$176K 0.02%
14,181
+1,361
+11% +$17.7K
GGN
97
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$762M
$36.6K ﹤0.01%
10,000
INTT icon
98
inTEST
INTT
$171M
-9,821
Closed -$258K
MMM icon
99
3M
MMM
$91.9B
-4,661
Closed -$390K

Similar funds

Maple Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Maple Capital Management held 99 positions worth $877M, down 4.5% from $918M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Maple Capital Management's Q3 2023 filing shows 4 new, 55 increased, 31 reduced and 2 closed positions. Its largest new stake was Veralto: 17,946 shares worth $1.52M. The largest sale was IBM, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Maple Capital Management's largest Q3 2023 buy was Veralto: 17,946 shares worth $1.52M.
  • Maple Capital Management added most to Air Products & Chemicals in Q3 2023, an estimated $4.21M increase.
  • Maple Capital Management's biggest Q3 2023 reduction was IBM, cutting an estimated $12.2M.
  • Maple Capital Management fully exited 3M in Q3 2023, selling an estimated $390K.
  • Maple Capital Management's ten largest holdings make up 51% of its $877M portfolio in Q3 2023.
  • Maple Capital Management opened 4 new positions and closed 2 in Q3 2023.
  • Maple Capital Management's portfolio value fell 4.5% quarter-over-quarter to $877M.

Based on Maple Capital Management's 13F filing for Q3 2023, filed 10 Oct 2023.